Novatreat Overview

  • Founded
  • 1997
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

Novatreat General Information

Description

Developer of products for the prevention and therapy of infectious diseases. The company develops immunoglobulin concentrate products from milk for preventing infectious diseases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Primary Office
  • Helsinki Science Park
  • Viikinkaari 6
  • 00710 Helsinki
  • Finland
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Novatreat Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 30-Jun-2004 Completed Generating Revenue
3. Secondary Transaction - Private 01-Sep-2003 Completed Generating Revenue
2. Early Stage VC 03-Jul-2000 Completed Startup
1. Early Stage VC 30-Jun-1998 Completed Startup
To view Novatreat’s complete valuation and funding history, request access »

Novatreat Executive Team (1)

Name Title Board Seat Contact Info
Jouni Aalto Ph.D Managing Director
To view Novatreat’s complete executive team members history, request access »

Novatreat Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Aboa Venture Management Venture Capital Minority 000 0000 000000 0
BioFund Ventures Venture Capital Minority 000 0000 000000 0
To view Novatreat’s complete investors history, request access »